Danaher (DHR) Projects 2026 Revenue Growth at TD Cowen 46th Annual Health Care Conference

Danaher Corporation (NYSE:DHR) is one of the 10 Best Diagnostics and Research Stocks to Buy According to Analysts. Danaher (DHR) Projects 2026 Revenue Growth at TD Cowen 46th Annual Health Care Conference On March 3, 2026, Danaher Corporation (NYSE:DHR) presented its 2026 strategic vision at the TD Cowen 46th Annual Health Care Conference. CEO Rainer Blair projected revenue growth of 3%-6% for 2026, driven by the bioprocessing segment. Also, the company anticipates a 100-basis-point operating margin expa ...